QQQ   310.73 (-0.32%)
AAPL   156.60 (+3.83%)
MSFT   262.15 (-0.93%)
META   193.04 (+2.26%)
GOOGL   107.15 (-0.55%)
AMZN   107.79 (-4.53%)
TSLA   195.80 (+4.00%)
NVDA   215.53 (-0.72%)
NIO   11.64 (-2.68%)
BABA   106.89 (-2.60%)
AMD   87.50 (-0.92%)
T   19.83 (-2.22%)
F   13.37 (-6.63%)
MU   63.17 (+0.00%)
CGC   3.04 (-3.18%)
GE   82.84 (-1.31%)
DIS   112.11 (-0.97%)
AMC   6.60 (+8.55%)
PFE   44.11 (-0.52%)
PYPL   87.11 (+0.17%)
NFLX   377.95 (+3.01%)
QQQ   310.73 (-0.32%)
AAPL   156.60 (+3.83%)
MSFT   262.15 (-0.93%)
META   193.04 (+2.26%)
GOOGL   107.15 (-0.55%)
AMZN   107.79 (-4.53%)
TSLA   195.80 (+4.00%)
NVDA   215.53 (-0.72%)
NIO   11.64 (-2.68%)
BABA   106.89 (-2.60%)
AMD   87.50 (-0.92%)
T   19.83 (-2.22%)
F   13.37 (-6.63%)
MU   63.17 (+0.00%)
CGC   3.04 (-3.18%)
GE   82.84 (-1.31%)
DIS   112.11 (-0.97%)
AMC   6.60 (+8.55%)
PFE   44.11 (-0.52%)
PYPL   87.11 (+0.17%)
NFLX   377.95 (+3.01%)
QQQ   310.73 (-0.32%)
AAPL   156.60 (+3.83%)
MSFT   262.15 (-0.93%)
META   193.04 (+2.26%)
GOOGL   107.15 (-0.55%)
AMZN   107.79 (-4.53%)
TSLA   195.80 (+4.00%)
NVDA   215.53 (-0.72%)
NIO   11.64 (-2.68%)
BABA   106.89 (-2.60%)
AMD   87.50 (-0.92%)
T   19.83 (-2.22%)
F   13.37 (-6.63%)
MU   63.17 (+0.00%)
CGC   3.04 (-3.18%)
GE   82.84 (-1.31%)
DIS   112.11 (-0.97%)
AMC   6.60 (+8.55%)
PFE   44.11 (-0.52%)
PYPL   87.11 (+0.17%)
NFLX   377.95 (+3.01%)
QQQ   310.73 (-0.32%)
AAPL   156.60 (+3.83%)
MSFT   262.15 (-0.93%)
META   193.04 (+2.26%)
GOOGL   107.15 (-0.55%)
AMZN   107.79 (-4.53%)
TSLA   195.80 (+4.00%)
NVDA   215.53 (-0.72%)
NIO   11.64 (-2.68%)
BABA   106.89 (-2.60%)
AMD   87.50 (-0.92%)
T   19.83 (-2.22%)
F   13.37 (-6.63%)
MU   63.17 (+0.00%)
CGC   3.04 (-3.18%)
GE   82.84 (-1.31%)
DIS   112.11 (-0.97%)
AMC   6.60 (+8.55%)
PFE   44.11 (-0.52%)
PYPL   87.11 (+0.17%)
NFLX   377.95 (+3.01%)
NASDAQ:GMDA

Gamida Cell - GMDA Stock Forecast, Price & News

$1.70
+0.03 (+1.79%)
(As of 02/3/2023 12:00 PM ET)
Add
Compare
Today's Range
$1.61
$1.70
50-Day Range
$1.15
$1.67
52-Week Range
$1.10
$4.72
Volume
178,679 shs
Average Volume
456,434 shs
Market Capitalization
$126.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.80

Gamida Cell MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
668.2% Upside
$12.80 Price Target
Short Interest
Bearish
6.17% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.18) to ($0.98) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.57 out of 5 stars

Medical Sector

896th out of 1,029 stocks

Biological Products, Except Diagnostic Industry

143rd out of 169 stocks

GMDA stock logo

About Gamida Cell (NASDAQ:GMDA) Stock

Gamida Cell Ltd. engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases. The firm offers Omidubicel, an investigational product with potential as a life-saving alternative for patients in need of a bone marrow transplant, and a line of modified and unmodified nicotinamide-enabled natural killer cells targeted at solid tumor and hematological malignancies. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Boston, MA.

Receive GMDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gamida Cell and its competitors with MarketBeat's FREE daily newsletter.

GMDA Stock News Headlines

Gamida Cell (GMDA) Upgraded to Buy: Here's Why
The Humble Mineral at the Heart of the EV Revolution (Not Lithium)
You may know of graphite as what's in the tip of a No. 2 pencil, but it is the key to many forms of renewable energy. Today, this humble mineral is at the epicenter of the electric car revolution. Because what most people don't know is today's EV batteries contain more than 220 pounds of graphite – more than lithium, copper or aluminum!
Gamida Cell Provides Regulatory Update on Omidubicel
The Humble Mineral at the Heart of the EV Revolution (Not Lithium)
You may know of graphite as what's in the tip of a No. 2 pencil, but it is the key to many forms of renewable energy. Today, this humble mineral is at the epicenter of the electric car revolution. Because what most people don't know is today's EV batteries contain more than 220 pounds of graphite – more than lithium, copper or aluminum!
Gamida Cell Names Abigail L. Jenkins as President, CEO
Earnings
See More Headlines
Receive GMDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gamida Cell and its competitors with MarketBeat's FREE daily newsletter.

GMDA Company Calendar

Last Earnings
11/14/2022
Today
2/03/2023
Next Earnings (Estimated)
3/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:GMDA
Fax
N/A
Employees
166
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$12.80
High Stock Price Forecast
$22.00
Low Stock Price Forecast
$7.00
Forecasted Upside/Downside
+653.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$-89,790,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.74 per share

Miscellaneous

Free Float
71,852,000
Market Cap
$126.44 million
Optionable
Not Optionable
Beta
1.67

Key Executives

  • Abigail L. Jenkins
    President, Chief Executive Officer & Director
  • Michele I. Korfin
    Chief Operating & Commercial Officer
  • Shai Lankry
    Chief Financial Officer
  • Ronit Simantov
    Chief Medical & Scientific Officer
  • Yona Geffen
    Vice President-Research & Development













GMDA Stock - Frequently Asked Questions

Should I buy or sell Gamida Cell stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Gamida Cell in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" GMDA shares.
View GMDA analyst ratings
or view top-rated stocks.

What is Gamida Cell's stock price forecast for 2023?

5 brokers have issued twelve-month price targets for Gamida Cell's shares. Their GMDA share price forecasts range from $7.00 to $22.00. On average, they predict the company's share price to reach $12.80 in the next year. This suggests a possible upside of 666.5% from the stock's current price.
View analysts price targets for GMDA
or view top-rated stocks among Wall Street analysts.

How have GMDA shares performed in 2023?

Gamida Cell's stock was trading at $1.29 at the beginning of 2023. Since then, GMDA shares have increased by 29.5% and is now trading at $1.67.
View the best growth stocks for 2023 here
.

Are investors shorting Gamida Cell?

Gamida Cell saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 4,590,000 shares, an increase of 15.3% from the December 31st total of 3,980,000 shares. Based on an average daily trading volume, of 522,700 shares, the days-to-cover ratio is presently 8.8 days.
View Gamida Cell's Short Interest
.

When is Gamida Cell's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 21st 2023.
View our GMDA earnings forecast
.

How were Gamida Cell's earnings last quarter?

Gamida Cell Ltd. (NASDAQ:GMDA) released its quarterly earnings data on Monday, November, 14th. The company reported ($0.29) EPS for the quarter, topping analysts' consensus estimates of ($0.31) by $0.02.

What other stocks do shareholders of Gamida Cell own?
When did Gamida Cell IPO?

(GMDA) raised $50 million in an initial public offering (IPO) on Friday, October 26th 2018. The company issued 3,600,000 shares at a price of $13.00-$15.00 per share. BMO Capital Markets and RBC Capital Markets served as the underwriters for the IPO and Needham & Company Oppenheimer & Co. was co-manager.

What is Gamida Cell's stock symbol?

Gamida Cell trades on the NASDAQ under the ticker symbol "GMDA."

Who are Gamida Cell's major shareholders?

Gamida Cell's stock is owned by a number of institutional and retail investors. Top institutional shareholders include FNY Investment Advisers LLC (0.26%), Stock Yards Bank & Trust Co. (0.07%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Abigail L Jenkins and Stephen T Wills.
View institutional ownership trends
.

How do I buy shares of Gamida Cell?

Shares of GMDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Gamida Cell's stock price today?

One share of GMDA stock can currently be purchased for approximately $1.67.

How much money does Gamida Cell make?

Gamida Cell (NASDAQ:GMDA) has a market capitalization of $124.21 million. The company earns $-89,790,000.00 in net income (profit) each year or ($1.28) on an earnings per share basis.

How many employees does Gamida Cell have?

The company employs 166 workers across the globe.

How can I contact Gamida Cell?

Gamida Cell's mailing address is 5 NAHUM HAFZADI STREET GIVAAT SHAUL, JERUSALEM L3, 91340. The official website for the company is www.gamida-cell.com. The company can be reached via phone at (713) 400-6400 or via email at irpr@gamida-cell.com.

This page (NASDAQ:GMDA) was last updated on 2/3/2023 by MarketBeat.com Staff